Skip to content

Clinical trials

Overweight trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: India Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20161
20183
20192
20202
20211
20221
20239
20242
20253
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting12
Active, not recruiting4
Not yet recruiting2
Enrolling by invitation1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company15
Novo Nordisk A/S10
AstraZeneca2
Bioagile Therapeutics Pvt. Ltd.2
Asir John Samuel1
Diabetes Foundation, India1
GlaxoSmithKline1
Hoffmann-La Roche1
Hofseth Biocare ASA1
JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight40
Obesity32
Diabetes Mellitus, Type 29
Sleep Apnea, Obstructive5
Nutrition Disorders3
Pediatric Obesity2
Prediabetic State2
Cardiovascular Diseases1
Dyslipidemias1
Glucose Intolerance1

Trials

Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.